However, given that GDM is associated with an increased risk of recurring GDM and both a short-term and long-term risk of maternal metabolic syndrome, type 2 diabetes, and cardiovascular disease [2,3,37], we know that endocrine dysfunction and corresponding systemic inflammation may be persistent and thereby influence milk CRP and other milk bioactives in the postpartum period. This evidence concerns the gene CRP and cardiovascular disorder.